Ewing's Sarcoma
Conference Coverage
Conference Coverage: ASCO 2019
From the Journals
Chromoplexy linked to aggressive Ewing sarcomas
Analysis of the sequence context surrounding chromoplexy breaks may provide clues and potentially point to a therapeutic vulnerability that could...
Conference Coverage
Lurbinectedin shows activity against relapsed Ewing’s
CHICAGO – The agent blocks DNA transcription and induces double-strand breaks leading to apoptosis; results warrant further exploration,...
Physician Resources
Ewing sarcoma: Professional resources from the National Cancer Institute
Clinical Trial Snapshot
Updates of ongoing clinical trials
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for...